Journal article
Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
Cell reports (Cambridge), Vol.5(4), pp.933-940
11/27/2013
DOI: 10.1016/j.celrep.2013.10.020
PMCID: PMC3893104
PMID: 24239359
Abstract
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, whereas undifferentiated pleomorphic sarcoma (UPS) is one of the most common soft tissue sarcomas diagnosed in adults. To investigate the myogenic cell(s) of origin of these sarcomas, we used Pax7-CreER and MyoD-CreER mice to transform Pax7+ and MyoD+ myogenic progenitors by expressing oncogenic KrasG12D and deleting Trp53 in vivo. Pax7-CreER mice developed RMS and UPS, whereas MyoD-CreER mice developed UPS. Using gene set enrichment analysis, RMS and UPS each clustered specifically within their human counterparts. These results suggest that RMS and UPS have distinct and overlapping cells of origin within the muscle lineage. Taking them together, we have established mouse models of soft tissue sarcoma from muscle stem and progenitor cells.
[Display omitted]
•Mouse RMS (mRMS) can be initiated in Pax7+MyoD− muscle stem cells•Mouse UPS (mUPS) can be initiated in Pax7+MyoD+ myogenic progenitors•mUPS cluster separately from mRMS by PCA and hierarchical clustering•mUPS and mRMS enrich in their human counterparts by GSEA
Cancer subtype can be influenced by cell of origin. Here, Kirsch and colleagues investigate the impact of cell of origin on sarcoma subtype by initiating mutations in muscle stem and progenitor cells. Tumor initiation in Pax7-expressing cells gave rise to rhabdomyosarcoma and undifferentiated pleomorphic sarcoma, whereas tumor initiation in MyoD-expressing cells gave rise to undifferentiated pleomorphic sarcoma. These results suggest that rhabdomyosarcoma can be initiated in muscle stem cells, whereas undifferentiated pleomorphic sarcoma can be initiated in activated satellite cells and myoblasts.
Details
- Title: Subtitle
- Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
- Creators
- Rebecca D Dodd - Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USAJordan M Blum - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USALeonor Añó - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USAZhizhong Li - Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USADavid Van Mater - Department of Pediatrics, Division of Hematology-Oncology, Duke University Medical Center, Durham, NC 27710, USABrian D Bennett - Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, NC 27710, USAMohit Sachdeva - Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USAIrina Lagutina - Department of Genetics, St. Jude Children’s Research Hospital, Memphis, TN 38105, USAMinsi Zhang - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USAJeffrey K Mito - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USALeslie G Dodd - Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USADiana M Cardona - Department of Pathology, Duke University Medical Center, Durham, NC 27710, USANerissa Williams - Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USAYan Ma - Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USAChristoph Lepper - Department of Embryology, Carnegie Institution of Washington, Baltimore, MD 21218, USACorinne M Linardic - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USASayan Mukherjee - Computational Biology and Bioinformatics Program, Duke University, Durham, NC 27710, USAGerard C Grosveld - Department of Genetics, St. Jude Children’s Research Hospital, Memphis, TN 38105, USAChen-Ming Fan - Department of Embryology, Carnegie Institution of Washington, Baltimore, MD 21218, USADavid G Kirsch - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA
- Resource Type
- Journal article
- Publication Details
- Cell reports (Cambridge), Vol.5(4), pp.933-940
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.celrep.2013.10.020
- PMID
- 24239359
- PMCID
- PMC3893104
- ISSN
- 2211-1247
- eISSN
- 2211-1247
- Language
- English
- Date published
- 11/27/2013
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094479102771
Metrics
25 Record Views